Polaris Venture Partners Special Founders' Fund V, L.p. - Net Worth and Insider Trading

Over the past 18 months, Polaris Venture Partners Special Founders' Fund V, L.p. made no insider transaction in Lyra Therapeutics Inc (LYRA). Other recent insider transactions involving Lyra Therapeutics Inc (LYRA) include a net purchase of 3,610,832 shares made by Perceptive Life Sciences Master Fund Ltd , a net purchase of 1,805,416 shares made by Edward T Anderson , and a net purchase of 1,805,416 shares made by Nbvm Gp, Llc .

In summary, during the past 3 months, insiders sold 0 shares of Lyra Therapeutics Inc (LYRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lyra Therapeutics Inc (LYRA) were sold and 7,246,664 shares were bought by its insiders, resulting in a net purchase of 7,246,664 shares.

Lyra Therapeutics Inc (LYRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Polaris Venture Partners Special Founders' Fund V, L.p. made no insider transaction in aTyr Pharma Inc (ATYR). Other recent insider transactions involving aTyr Pharma Inc (ATYR) include a net purchase of 65,000 shares made by Sanjay Shukla , a net purchase of 1,844 shares made by Jill Marie Broadfoot , and a net purchase of 200,000 shares made by Paul Schimmel .

In summary, during the past 3 months, insiders sold 0 shares of aTyr Pharma Inc (ATYR) in total and bought 75,000 shares, with a net purchase of 75,000 shares. During the past 18 months, 3,156 shares of aTyr Pharma Inc (ATYR) were sold and 320,000 shares were bought by its insiders, resulting in a net purchase of 316,844 shares.

aTyr Pharma Inc (ATYR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Polaris Venture Partners Special Founders' Fund V, L.p. made no insider transaction in Ocular Therapeutix Inc (OCUL). Other recent insider transactions involving Ocular Therapeutix Inc (OCUL) include a net sale of 51,149 shares made by Antony C. Mattessich , a net sale of 21,358 shares made by Rabia Gurses Ozden , and a net sale of 19,121 shares made by Donald Notman .

In summary, during the past 3 months, insiders sold 23,900 shares of Ocular Therapeutix Inc (OCUL) in total and bought 0 shares, with a net sale of 23,900 shares. During the past 18 months, 157,955 shares of Ocular Therapeutix Inc (OCUL) were sold and 2,475,812 shares were bought by its insiders, resulting in a net purchase of 2,317,857 shares.

Ocular Therapeutix Inc (OCUL)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Dare Bioscience Inc (DARE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dare Bioscience Inc (DARE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Dare Bioscience Inc (DARE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Polaris Venture Partners Special Founders' Fund V, L.p. made no insider transaction in Phreesia Inc (PHR). Other recent insider transactions involving Phreesia Inc (PHR) include a net sale of 67,497 shares made by David Linetsky , a net sale of 11,597 shares made by Janet Gunzburg , and a net sale of 94,627 shares made by Evan Roberts .

In summary, during the past 3 months, insiders sold 97,803 shares of Phreesia Inc (PHR) in total and bought 0 shares, with a net sale of 97,803 shares. During the past 18 months, 462,587 shares of Phreesia Inc (PHR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 462,587 shares.

Phreesia Inc (PHR)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Trevena Inc (TRVN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Trevena Inc (TRVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Trevena Inc (TRVN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Polaris Venture Partners Special Founders' Fund V, L.p. made no insider transaction in Fate Therapeutics Inc (FATE). Other recent insider transactions involving Fate Therapeutics Inc (FATE) include a net sale of 26,108 shares made by Dulac Edward J Iii , a net purchase of 44,630 shares made by Redmile Group, Llc , and a net sale of 46,790 shares made by Cindy Tahl .

In summary, during the past 3 months, insiders sold 0 shares of Fate Therapeutics Inc (FATE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 479,444 shares of Fate Therapeutics Inc (FATE) were sold and 471,648 shares were bought by its insiders, resulting in a net sale of 7,796 shares.

Fate Therapeutics Inc (FATE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Polaris Venture Partners Special Founders' Fund V, L.p. made no insider transaction in Cartesian Therapeutics Inc (RNAC). Other recent insider transactions involving Cartesian Therapeutics Inc (RNAC) include a net purchase of 1,223,316 shares made by Timothy A Springer , a net sale of 44,002 shares made by Carsten Brunn , and a net sale of 12,349 shares made by Peter G Traber .

In summary, during the past 3 months, insiders sold 0 shares of Cartesian Therapeutics Inc (RNAC) in total and bought 40,777 shares, with a net purchase of 40,777 shares. During the past 18 months, 2,531 shares of Cartesian Therapeutics Inc (RNAC) were sold and 40,777 shares were bought by its insiders, resulting in a net purchase of 38,247 shares.

Cartesian Therapeutics Inc (RNAC)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Genocea Biosciences Inc (GNCAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Genocea Biosciences Inc (GNCAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Genocea Biosciences Inc (GNCAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Polaris Venture Partners Special Founders' Fund V, L.p. made no insider transaction in Kala Bio Inc (KALA). Other recent insider transactions involving Kala Bio Inc (KALA) include a net sale of 12,129 shares made by Mark T Iwicki , a net sale of 3,692 shares made by Romulus K Brazzell , and a net sale of 3,560 shares made by Todd Bazemore .

In summary, during the past 3 months, insiders sold 13,504 shares of Kala Bio Inc (KALA) in total and bought 0 shares, with a net sale of 13,504 shares. During the past 18 months, 25,357 shares of Kala Bio Inc (KALA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 25,357 shares.

Kala Bio Inc (KALA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Polaris Venture Partners Special Founders' Fund V, L.p. made no insider transaction in T2 Biosystems Inc (TTOO). Other recent insider transactions involving T2 Biosystems Inc (TTOO) include a net sale of 48,345,798 shares made by Cr Group L.p. , a net sale of 3,969 shares made by Michael Terrence Gibbs , and a net sale of 1,074 shares made by Brett A. Giffin .

In summary, during the past 3 months, insiders sold 0 shares of T2 Biosystems Inc (TTOO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 48,363,307 shares of T2 Biosystems Inc (TTOO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 48,363,307 shares.

T2 Biosystems Inc (TTOO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Polaris Venture Partners Special Founders' Fund V, L.p. made no insider transaction in X4 Pharmaceuticals Inc (XFOR). Other recent insider transactions involving X4 Pharmaceuticals Inc (XFOR) include a net sale of 401,923 shares made by Paula Ragan , a net sale of 113,683 shares made by Mary Dibiase , and a net sale of 401,921 shares made by Adam S. Mostafa .

In summary, during the past 3 months, insiders sold 0 shares of X4 Pharmaceuticals Inc (XFOR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,158,291 shares of X4 Pharmaceuticals Inc (XFOR) were sold and 25,000 shares were bought by its insiders, resulting in a net sale of 1,133,291 shares.

X4 Pharmaceuticals Inc (XFOR)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Pulmatrix Inc (PULM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pulmatrix Inc (PULM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Pulmatrix Inc (PULM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Polaris Venture Partners Special Founders' Fund V, L.p. made no insider transaction in Cardlytics Inc (CDLX). Other recent insider transactions involving Cardlytics Inc (CDLX) include a net sale of 368,506 shares made by Karim Saad Temsamani , a net sale of 63,635 shares made by Nicholas Hollmeyer Lynton , and a net purchase of 1,652,052 shares made by Clifford Sosin .

In summary, during the past 3 months, insiders sold 111,999 shares of Cardlytics Inc (CDLX) in total and bought 1,669,207 shares, with a net purchase of 1,557,208 shares. During the past 18 months, 559,423 shares of Cardlytics Inc (CDLX) were sold and 1,669,207 shares were bought by its insiders, resulting in a net purchase of 1,109,784 shares.

Cardlytics Inc (CDLX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Polaris Venture Partners Special Founders' Fund V, L.p. made no insider transaction in Invivyd Inc (IVVD). Other recent insider transactions involving Invivyd Inc (IVVD) include a net sale of 5,000,000 shares made by Adimab, Llc , and a net sale of 112,381 shares made by Terrance Mcguire .

In summary, during the past 3 months, insiders sold 112,381 shares of Invivyd Inc (IVVD) in total and bought 0 shares, with a net sale of 112,381 shares. During the past 18 months, 5,112,381 shares of Invivyd Inc (IVVD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 5,112,381 shares.

Invivyd Inc (IVVD)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Genocea Biosciences Inc (GGNNQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Genocea Biosciences Inc (GGNNQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Genocea Biosciences Inc (GGNNQ)'s detailed insider trading history can be found in Insider Trading Tracker table.